Search Results - "Gawor, Monika"
-
1
Cardiac biomarkers in chronic kidney disease are independently associated with myocardial edema and diffuse fibrosis by cardiovascular magnetic resonance
Published in Journal of cardiovascular magnetic resonance (07-06-2021)“…High sensitivity cardiac troponin T (hs-cTnT) and NT-pro-brain natriuretic peptide (NT-pro BNP) are often elevated in chronic kidney disease (CKD) and…”
Get full text
Journal Article -
2
Sudden cardiac death risk in hypertrophic cardiomyopathy: comparison between echocardiography and magnetic resonance imaging
Published in Scientific reports (30-03-2021)“…In hypertrophic cardiomyopathy (HCM) patients, left ventricular (LV) maximal wall thickness (MWT) is one of the most important factors determining sudden…”
Get full text
Journal Article -
3
Aortic Stiffness and Heart Failure in Chronic Kidney Disease
Published in Current cardiovascular imaging reports (01-04-2020)“…Purpose of Review To provide an update on the recent findings in the field of aortic stiffness and heart failure in patients with chronic kidney disease (CKD)…”
Get full text
Journal Article -
4
CMR in Pericardial Diseases - an Update
Published in Current cardiovascular imaging reports (01-04-2020)“…Purpose of Review To review the latest developments and the current role of the cardiac magnetic resonance (CMR) in pericardial diseases and their…”
Get full text
Journal Article -
5
Quantification of mitral regurgitation in patients with hypertrophic cardiomyopathy using aortic and pulmonary flow data: impacts of left ventricular outflow tract obstruction and different left ventricular segmentation methods
Published in Journal of cardiovascular magnetic resonance (21-12-2017)“…Cardiovascular magnetic resonance (CMR) imaging in patients with hypertrophic cardiomyopathy (HCM) enables the assessment of not only left ventricular (LV)…”
Get full text
Journal Article -
6
Perfusion cardiovascular magnetic resonance as the first-line technique in patients with stable chest pain
Published in Kardiologia polska (25-02-2020)“…Perfusion imaging with cardiovascular magnetic resonance is a noninvasive test free of ionizing radiation recommended by the latest European Society of…”
Get full text
Journal Article -
7
Myocardial Fibrosis and Inflammation by CMR Predict Cardiovascular Outcome in People Living With HIV
Published in JACC. Cardiovascular imaging (01-08-2021)“…The goal of this study was to examine prognostic relationships between cardiac imaging measures and cardiovascular outcome in people living with human…”
Get full text
Journal Article -
8
Circulating biomarkers of hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy assessed by cardiac magnetic resonance
Published in Biomarkers (03-10-2018)“…Background: Myocardial fibrosis in hypertrophic cardiomyopathy (HCM) is associated with worse clinical outcomes. The availability of circulating biomarkers of…”
Get full text
Journal Article -
9
Recovery from heart failure in a patient with cardiac amyloidosis treated with autologous stem cell transplantation
Published in Kardiologia polska (01-01-2017)Get full text
Journal Article -
10
Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis
Published in Cardiology journal (13-12-2022)“…Transthyretin amyloidosis (ATTR) is a rare, life-threatening systemic disorder. We present first findings on the cardiac hereditary ATTR in Poland. Sixty-eight…”
Get full text
Journal Article -
11
-
12
Galectin-3 plasma levels in adult congenital heart disease and the pressure overloaded right ventricle: reason matters
Published in Biomarkers in medicine (01-09-2020)“…To assess galectin-3 (Gal-3) levels and their relationship with clinical status and right ventricular (RV) performance in adults with RV pressure overload of…”
Get full text
Journal Article -
13
-
14
The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy
Published in Kardiologia polska (01-01-2017)“…Estimation of sudden cardiac death (SCD) risk is an integral part of clinical management of patients with hypertrophic cardiomyopathy (HCM). Identification of…”
Get full text
Journal Article -
15
Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland - genetic and clinical presentation
Published in Neurologia i neurochirurgia polska (01-01-2020)“…Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) is a rare, progressive, hereditary, highly disabling multisystem disorder. ATTR-FAP phenotypes…”
Get more information
Journal Article -
16
A new missense mutation, p.Arg719Leu, of the beta-myosin heavy chain gene in a patient with familial hypertrophic cardiomyopathy
Published in Minerva cardioangiologica (01-02-2017)Get more information
Journal Article -
17
-
18
Clinical features, etiology and survival in patients with restrictive cardiomyopathy: A single center experience
Published in Kardiologia polska (1957) (2023)Get full text
Journal Article -
19
Clinical features, etiology, and survival in patients with restrictive cardiomyopathy: A single-center experience
Published in Kardiologia polska (2023)“…Numerous prognostic factors have been proposed for cardiac amyloidosis (CA). The knowledge about other subtypes of restrictive cardiomyopathy (RCM) is scant…”
Get more information
Journal Article